Keel Point’s Boston Scientific BSX Stock Holding History

Keel Point’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6M	Buy	41,464 +3,064	+8%	+$245K	0.17%	83
2025 Q4	$3.66M	Buy	38,400 +32,409	+541%	+$3.18M	0.22%	68
2025 Q3	$585K	Sell	5,991 -183	-3%	-$19K	0.04%	267
2025 Q2	$663K	Buy	6,174 +745	+14%	+$75.4K	0.04%	241
2025 Q1	$548K	Buy	5,429 +1,153	+27%	+$116K	0.04%	234
2024 Q4	$382K	Buy	4,276 +457	+12%	+$40.2K	0.03%	281
2024 Q3	$320K	Sell	3,819 -99	-3%	-$7.8K	0.03%	317
2024 Q2	$297K	Sell	3,918 -575	-13%	-$42.1K	0.03%	319
2024 Q1	$308K	Sell	4,493 -199	-4%	-$12.8K	0.03%	280
2023 Q4	$271K	Buy	4,692 +405	+9%	+$21.6K	0.03%	273
2023 Q3	$226K	Sell	4,287 -297	-6%	-$15.6K	0.03%	281
2023 Q2	$248K	Buy	+4,584	New	+$239K	0.03%	272
2023 Q1	–	Sell	-4,331	Closed	-$200K	–	309
2022 Q4	$200K	Buy	+4,331	New	+$188K	0.03%	282

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Keel Point's BSX Position: Q1 2026 in Review

Keel Point increased its Boston Scientific (BSX) stake by 8% in Q1 2026, buying an estimated $245K and bringing the position to 41,464 shares worth $2.6M. The position accounts for 0.17% of the portfolio, ranked #83.

Keel Point first reported a position in BSX in Q4 2022 and has held it in 13 quarters since. The position peaked at $3.66M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Keel Point held 41,464 shares of Boston Scientific worth $2.6M as of Q1 2026.
Keel Point bought 3,064 Boston Scientific shares in Q1 2026, an estimated $245K.
Boston Scientific made up 0.17% of Keel Point's portfolio in Q1 2026, its #83 holding.
Keel Point first reported a position in Boston Scientific in Q4 2022 and has held it in 13 quarters since.
Keel Point's Boston Scientific position peaked at $3.66M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.